Suchergebnisse - "van der Heijde, Désirée"

PubPharm (77)

1

Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs : two phase 3 randomised trials (contRAst 1 and contRAst 2)

enthalten in: Annals of the rheumatic diseases | 2023

von Fleischmann, R. | van der Heijde, D. | Strand, V. | +19

2

Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy : 1-year results from the open-label extension of a phase III study

enthalten in: Arthritis research & therapy | 2023

von Baraliakos, X. | van der Heijde, D. | Sieper, J. | +8

3

Clinimetric Validation of the Assessment of Spondyloarthritis International Society Health Index in Patients With Radiographic Axial Spondyloarthritis in Ixekizumab Trials

enthalten in: The Journal of rheumatology | 2023

von Kiltz, U. | van der Heijde, D. | Boonen, A. | +5

CommentIn: J Rheumatol. 2023 Jun;50(6):724-725. - PMID 37061227

4

Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis

enthalten in: Arthritis research & therapy | 2023

von Braun, J. | Blanco, R. | Marzo-Ortega, H. | +12

5

Post hoc analysis of clinical characteristics of patients with radiographic progression in a Japanese phase 3 trial of peficitinib and methotrexate treatment (RAJ4)

enthalten in: Modern rheumatology | 2023

von Tanaka, Y. | Takeuchi, T. | Kato, D. | +5

6

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy : a double-blind, randomised, placebo-controlled phase 3 trial

enthalten in: Annals of the rheumatic diseases | 2022

von van der Heijde, D. | Baraliakos, X. | Sieper, J. | +9

7

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2) : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2022

von Deodhar, A. | Van den Bosch, F. | Poddubnyy, D. | +10

CommentIn: Lancet. 2022 Jul 30;400(10349):340-341. - PMID 35908562

8

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial

enthalten in: Arthritis care & research | 2022

von Walsh, J. | Magrey, M. | Baraliakos, X. | +14

9

Long-Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through Two Years : Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2022

von McInnes, I. | Rahman, P. | Gottlieb, A. | +9

10

Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis : Results From RA-BEYOND

enthalten in: The Journal of rheumatology | 2022

von van der Heijde, D. | Kartman, C. | Xie, L. | +6

1
2
3
4
5
6
7
8
Nächster »
[8]